
Yuvezzi’s Health Canada submission leads this week’s recap, plus AI front desks, the EMERALD trial, and Alberta’s scope expansion.
When we need a good laugh, we love to head over to Twitter and find out what patients are saying about their optometrists. Check out what they had to say.
When we need a good laugh, we love to head over to Twitter and find out what patients are saying about their optometrists. Check out what they had to say.
Related:
Related:





